Enhancing Pharmacovigilance and Post-Market Surveillance
The responsibility of a pharmaceutical company does not end when a drug receives FDA approval. In fact, monitoring the safety and efficacy of a therapeutic once it reaches the general public is one of the most critical, highly regulated, and legally perilous phases of the drug lifecycle. To manage this massive operational burden, the Life Science Analytics Market has developed incredibly...
0 Комментарии 0 Поделились 280 Просмотры 0 предпросмотр